Author Steve Elliott ~alapoet~

Photo: NORML Blog

By Jack Rikess

Toke of the Town

Northern California Correspondent

11. Wars make money for a few and kill the rest…

The War On Drugs makes money for cartels, police, the government, prisons, politicians, crooks, and all those other people we can’t see, like the Glad Bag people and the grow-light industry.
This 100-year revenue stream could dry up if Americans couldn’t be arrested for a drug that has been proven to be less destructive than whole milk.

Photo: The Boston Phoenix
More than 80 people, mostly medical marijuana supporters, packed the conference room for the hearing before the Joint Committee on Public Health.

​Massachusetts lawmakers are considering a bill that would legalize the medicinal use of marijuana to ease symptoms of chronic and debilitating illnesses, and regulate the centers that distribute the herb.

“Marijuana has proven its medical efficacy,” Rep. Frank Smizik (D-Brookline) testified before the Legislature’s public health committee on Tuesday, reports the Associated Press. “This bill is about more than just common sense, it’s about compassion.”
Smizik is one of 27 House co-sponsors of H 625, which would legalize and regulate the use of cannabis for patients with specific illnesses.

Photo: Reason

​The Netherlands, renowned worldwide for its liberal cannabis policies, is one step closer to requiring “weed passes” to discourage sales of marijuana to foreign tourists, following a court ruling on Wednesday.

Dutch “coffee shops” openly sell cannabis flowers and hashish to customers, and are popular with foreign tourists. But the shops have faced tighter controls over the past three years as successive governments pushed to discourage the use and sale of “soft drugs” on health and crime grounds, reports Reuters.
Many of the coffee shops in Amsterdam and elsewhere in the Netherlands oppose the “weed pass” plan, maintaining that it is discriminatory and will kill the cannabis tourism industry.

Graphic: BudGenius

Artificial-Intelligence Software “BudGenius” Correlates Chemical Analysis with Online Patient Feedback

BudGenius.com, a social networking website and medical marijuana testing laboratory (now there’s a 21st Century combination for you!), says it has developed technology to predict therapeutic effects for thousands of marijuana strains by combining scientific data and crowd-sourced reviews.
Patients throughout California use the online service to select cannabis individually rated for pain relief, sleep aid, anxiety relief, nausea treatment, appetite stimulation, and mood modification. BudGenius says it plans to extend treatment options to target cancer, Parkinson’s disease, and Alzheimer’s within a year.
Patients search online at BudGenius.com to find locally available marijuana treatments that meet their requirements. Patients are also given the option to visit participating dispensaries and review onsite educational materials.

Photo: Psychedelic Press UK
James L. Kent, author of “Psychedelic Information Theory” and editor of dosenation.com

​Even a single, low-dose psychedelic experience can produce changes in identity and transpersonal awareness that last a lifetime. How and why does this happen?

When most of us take psychedelics like LSD, sure, it’s one of the strangest — and most meaningful — experiences we’ve ever had, and as we move on with our lives, we tend to just classify what happened under the general category of “that was weird.”

Some folks, though — those of a more analytical and scientific bent — aren’t content to do only that. James L. Kent, author of Psychedelic Information Theory: Shamanism in the Age of Reason definitely belongs to this more analytical category of trippers. These folks want to analyze the psychedelic trip right down to which neurons were activated, how, and why.

Photo: The Julius Axelrod Papers
Dr. Julius Axelrod, pictured above, conducted some of the original research which culminated in the United States government getting a patent on all cannabinoids in 2003.

​​​Welcome to Room 420, where your instructor is Mr. Ron Marczyk and your subjects are wellness, disease prevention, self actualization, and chillin’.


Worth Repeating
By Ron Marczyk, R.N.

Health Education Teacher (Retired)

The United States federal government holds a “medical patent” for all cannabinoids — a patent which it has held since 2003.
Let’s take a look at the rationale behind this patent, and highlight the good news it actually contains for disease prevention, medical treatment and for cannabis legalization.
This patent was the outcome from research conducted by:
• Dr. Aiden J. Hampson, a neuropharmacologist at the National Institute for Mental Health (NIMH) in Bethesda, Maryland 
• Dr. Julius Axelrod (1912-2004), Professor Emeritus, National Institutes of Health, pharmacologist and neuroscientist who shared the 1970 Nobel Prize in Physiology and Medicine
• Dr. Maurizio Grimaldi, professor of neurology/neuropsychopharmacology and toxicology, NIMH
Here’s how it all went down in 1998.
1 163 164 165 166 167 377